Journal article · 2026 · Open access

NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER

Gauri, Anju Goyal, Jitender Singh, Puneet Sudan, Sachin Kumar Sharma

Genetics and Molecular Research · Published 2 June 2026 · DOI 10.4238/0fganh12

Free PDFView at the publisherCite this paper

In brief

“NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER” is a 2026 journal article by Gauri and 4 co-authors, published in Genetics and Molecular Research. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY-SA licence: the full text is free to read at Genetics and Molecular Research.

Citations
0
References
15
Authors
5

Abstract

One of the biggest health issues of the twenty-first century is Alzheimer's disease (AD), which is the most prevalent cause of dementia. With an estimated 40 million affected worldwide, the number is expected to increase significantly as the population ages, resulting in significant medical, social, and financial problems. Common neuropathological alterations that contribute to cognitive decline and functional impairment include amyloid-β (Aβ) plaque accumulation, neurofibrillary tangles made of hyperphosphorylated tau protein, synaptic dysfunction, and progressive neuronal loss. The exact cause of AD is still unknown despite decades of research, involving a complex interaction of lifestyle, environmental, and genetic factors. The chance of developing the condition is greatly increased by the apolipoprotein E (APOE) ε4 allele, mutations in APP, PSEN1, and PSEN2, and modifiable variables such cardiovascular diseases, traumatic brain injury, and lifestyle choices. Memantine, an NMDA receptor antagonist, and cholinesterase inhibitors (donepezil, rivastigmine, galantamine) are examples of current pharmaceutical treatments that provide symptomatic relief without changing the course of the disease. Disease-modifying monoclonal antibodies that target Aβ, such as aducanumab and lecanemab, have recently raised cautious optimism, despite ongoing concerns about accessibility, safety, and efficacy. The need for a better understanding of AD pathophysiology and the conversion of basic science into useful clinical interventions is underscored by the growing emphasis on novel therapeutic approaches, such as gene-based interventions, neuroprotective approaches, and lifestyle changes. This review highlights new avenues for therapy development while giving a broad overview of the genesis, pathophysiology, and current therapeutic landscape of AD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gauri, Goyal, A., Singh, J., Sudan, P., & Sharma, S. K. (2026). NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER. Genetics and Molecular Research. https://doi.org/10.4238/0fganh12

MLA 9

Gauri, et al. “NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER.” Genetics and Molecular Research, 2026. https://doi.org/10.4238/0fganh12.

Chicago

Gauri, Anju Goyal, Jitender Singh, Puneet Sudan, and Sachin Kumar Sharma. 2026. “NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER.” Genetics and Molecular Research. https://doi.org/10.4238/0fganh12.

Harvard

Gauri et al. (2026) ‘NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER’, Genetics and Molecular Research. doi:10.4238/0fganh12.

IEEE

Gauri, A. Goyal, J. Singh, P. Sudan, and S. K. Sharma, “NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER,” Genetics and Molecular Research, 2026, doi: 10.4238/0fganh12.

BibTeX

@article{gauri2026novel,
  title     = {{NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER}},
  author    = {Gauri and Goyal, Anju and Singh, Jitender and Sudan, Puneet and Sharma, Sachin Kumar},
  journal   = {Genetics and Molecular Research},
  year      = {2026},
  doi       = {10.4238/0fganh12},
  url       = {https://doi.org/10.4238/0fganh12}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • drug delivery systems
  • amyloid plaques
  • tau hyperphosphorylation
  • APOE ε4
  • NMDA receptor antagonists
  • cholinesterase inhibitors
  • aducanumab

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Gauri, Goyal, A., Singh, J., Sudan, P., & Sharma, S. K. (2026). NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER. Genetics and Molecular Research. https://doi.org/10.4238/0fganh12

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Genetics and Molecular Research.

Who wrote this paper?

Gauri, Anju Goyal, Jitender Singh, Puneet Sudan, Sachin Kumar Sharma.

What is the DOI of this paper?

10.4238/0fganh12. The permanent link is https://doi.org/10.4238/0fganh12.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.